600 filings
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
19 Mar 24
Submission of Matters to a Vote of Security Holders
4:38pm
8-K/A
ARWR
Arrowhead Pharmaceuticals Inc.
15 Mar 24
Departure of Directors or Certain Officers
7:21pm
S-8
ARWR
Arrowhead Pharmaceuticals Inc.
28 Feb 24
Registration of securities for employees
5:25pm
DEFA14A
ARWR
Arrowhead Pharmaceuticals Inc.
27 Feb 24
Additional proxy soliciting materials
5:08pm
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
21 Feb 24
Departure of Directors or Certain Officers
5:42pm
8-K
uifz3p
6 Feb 24
Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
4:07pm
ARS
jbqsj5rhlknbv
29 Jan 24
Annual report to shareholders
12:00am
DEFA14A
mf6ggj0he690n3i1us
26 Jan 24
Additional proxy soliciting materials
5:28pm
8-K
ilkcp4q0 20yqj9flu
22 Jan 24
Departure of Directors or Certain Officers
12:00am
8-K
9lr qly2pqhjqgnvu
4 Jan 24
Entry into a Material Definitive Agreement
5:27pm
424B5
pl9n6m
4 Jan 24
Prospectus supplement for primary offering
5:01pm
8-K
g3j ewy9hd5vxh3r7go
5 Dec 23
Changes in Registrant's Certifying Accountant
5:16pm
8-K
sphfzq5zxwz0bd5
29 Nov 23
Arrowhead Pharmaceuticals Reports Fiscal 2023 Year End Results
4:10pm
8-K
1lw1v7
7 Aug 23
Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results
4:10pm
UPLOAD
u1ukzd k55md
19 May 23
Letter from SEC
12:00am
8-K
aco8sebro48ov37dh49
2 May 23
Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results
4:09pm